Xiuhua Pan

570 total citations
24 papers, 437 citations indexed

About

Xiuhua Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Xiuhua Pan has authored 24 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Biomedical Engineering. Recurrent topics in Xiuhua Pan's work include Nanoplatforms for cancer theranostics (9 papers), Ferroptosis and cancer prognosis (8 papers) and RNA Interference and Gene Delivery (5 papers). Xiuhua Pan is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Ferroptosis and cancer prognosis (8 papers) and RNA Interference and Gene Delivery (5 papers). Xiuhua Pan collaborates with scholars based in China, Australia and Japan. Xiuhua Pan's co-authors include Zhenghong Wu, Xiaole Qi, Jun Zhang, Qi Shen, Nan Su, Hanitrarimalala Veroniaina, Jie Yang, Yawen Wei, Siyu Ma and Haiqin Huang and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Journal of Colloid and Interface Science.

In The Last Decade

Xiuhua Pan

24 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuhua Pan China 14 223 128 115 95 68 24 437
Vicenta Trujillo-Alonso United States 7 182 0.8× 85 0.7× 104 0.9× 63 0.7× 77 1.1× 7 481
Yangchun Zhou China 9 328 1.5× 90 0.7× 160 1.4× 82 0.9× 59 0.9× 11 516
Chenglong Ge China 13 366 1.6× 85 0.7× 158 1.4× 50 0.5× 107 1.6× 27 649
Matthew W. Fittall United Kingdom 4 202 0.9× 56 0.4× 108 0.9× 68 0.7× 50 0.7× 8 452
Xianying Meng China 15 261 1.2× 64 0.5× 113 1.0× 149 1.6× 40 0.6× 38 529
Jingkang He China 12 176 0.8× 99 0.8× 190 1.7× 65 0.7× 28 0.4× 19 457
Daniel P. Feldmann United States 8 224 1.0× 86 0.7× 48 0.4× 76 0.8× 26 0.4× 10 418
Anliang Huang China 10 225 1.0× 45 0.4× 79 0.7× 91 1.0× 83 1.2× 22 426
Zhenwei Deng China 10 144 0.6× 70 0.5× 94 0.8× 97 1.0× 56 0.8× 20 378
Marall Vedaie United States 8 255 1.1× 185 1.4× 85 0.7× 43 0.5× 25 0.4× 11 512

Countries citing papers authored by Xiuhua Pan

Since Specialization
Citations

This map shows the geographic impact of Xiuhua Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuhua Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuhua Pan more than expected).

Fields of papers citing papers by Xiuhua Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuhua Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuhua Pan. The network helps show where Xiuhua Pan may publish in the future.

Co-authorship network of co-authors of Xiuhua Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuhua Pan. A scholar is included among the top collaborators of Xiuhua Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuhua Pan. Xiuhua Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Yiwei, et al.. (2025). Biomimetic mineralized mesenchymal stem cell-derived exosomes for dual modulation of ferroptosis and lactic acid-driven inflammation in acute liver injury therapy. Journal of Colloid and Interface Science. 687. 489–506. 4 indexed citations
2.
Pan, Xiuhua, Yiwei Tian, Jun Zhang, et al.. (2025). Sustained-release hydrogel system for preventing postoperative tumor recurrence through synergistic immune signal enhancement for T cell activation. Journal of Colloid and Interface Science. 699(Pt 1). 138158–138158. 1 indexed citations
3.
4.
Zafar, Hajra, et al.. (2024). Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation. Journal of Controlled Release. 372. 446–466. 26 indexed citations
5.
Wu, Jinxia, Chunyang Liu, Ke‐Xue Li, et al.. (2024). Genistein alleviates doxorubicin‐induced cardiomyocyte autophagy and apoptosis via ERK/STAT3/c‐Myc signaling pathway in rat model. Phytotherapy Research. 38(8). 3921–3934. 7 indexed citations
6.
Adu‐Amankwaah, Joseph, Adebayo Oluwafemi Adekunle, Ziqing Tang, et al.. (2024). Estradiol contributes to sex differences in resilience to sepsis-induced metabolic dysregulation and dysfunction in the heart via GPER-1-mediated PPARδ/NLRP3 signaling. Metabolism. 156. 155934–155934. 14 indexed citations
7.
Pan, Xiuhua, et al.. (2024). Self‐Adjuvanting Bacteria Hydrogel for SHP1 Checkpoint Inhibition in Tumor‐Draining Lymph Nodes to Enhance Cancer Immunotherapy. Advanced Functional Materials. 34(51). 4 indexed citations
8.
Yang, Ning, et al.. (2023). Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy. Journal of Colloid and Interface Science. 658. 100–113. 24 indexed citations
9.
Ma, Siyu, Liang Xiao, Ning Yang, et al.. (2022). Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties. Biomaterials Science. 11(2). 518–532. 21 indexed citations
10.
Yang, Jie, Jun Zhang, Xiuhua Pan, et al.. (2022). Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance. Advanced Healthcare Materials. 11(13). e2102799–e2102799. 58 indexed citations
11.
Pan, Xiuhua, Haiqin Huang, Nan Su, et al.. (2021). One-in-one individual package and delivery of CRISPR/Cas9 ribonucleoprotein using apoferritin. Journal of Controlled Release. 337. 686–697. 23 indexed citations
12.
Pan, Xiuhua, et al.. (2021). Mitochondria-targeted curcumin loaded CTPP–PEG–PCL self-assembled micelles for improving liver fibrosis therapy. RSC Advances. 11(10). 5348–5360. 14 indexed citations
13.
Veroniaina, Hanitrarimalala, Xiuhua Pan, Zhenghong Wu, & Xiaole Qi. (2021). Apoferritin: a potential nanocarrier for cancer imaging and drug delivery. Expert Review of Anticancer Therapy. 21(8). 901–913. 15 indexed citations
14.
Pan, Xiuhua, et al.. (2021). Applications and developments of gene therapy drug delivery systems for genetic diseases. Asian Journal of Pharmaceutical Sciences. 16(6). 687–703. 89 indexed citations
15.
Song, Ting, et al.. (2021). PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma. International Journal of General Medicine. Volume 14. 4209–4218. 4 indexed citations
16.
Pan, Xiuhua, Xiaoyi Xu, Xiang Xu, et al.. (2020). 4T1 cell membrane fragment reunited PAMAM polymer units disguised as tumor cell clusters for tumor homotypic targeting and anti-metastasis treatment. Biomaterials Science. 9(4). 1325–1333. 19 indexed citations
17.
Pan, Xiuhua, Nan Su, Jiachen Li, et al.. (2020). Tetralysine modified H-chain apoferritin mediated nucleus delivery of chemotherapy drugs synchronized with passive diffusion. Journal of Drug Delivery Science and Technology. 61. 102132–102132. 4 indexed citations
18.
Li, Xuyan, et al.. (2018). Tumor-Suppressive MicroRNA-708 Targets Notch1 to Suppress Cell Proliferation and Invasion in Gastric Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 26(9). 1317–1326. 7 indexed citations
19.
Chen, Hualin, et al.. (2012). Lactoferrin protects against lipopolysaccharide-induced acute lung injury in mice. International Immunopharmacology. 12(2). 460–464. 25 indexed citations
20.
Feng, Yu-Mei, Xiaoqing Li, Baocun Sun, et al.. (2009). Evidence for a transcriptional signature of breast cancer. Breast Cancer Research and Treatment. 122(1). 65–75. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vicenta Trujillo-Alonso Breakdown of academic impact, for papers by Yangchun Zhou Breakdown of academic impact, for papers by Chenglong Ge Breakdown of academic impact, for papers by Matthew W. Fittall Breakdown of academic impact, for papers by Xianying Meng Breakdown of academic impact, for papers by Jingkang He Breakdown of academic impact, for papers by Daniel P. Feldmann Breakdown of academic impact, for papers by Anliang Huang Breakdown of academic impact, for papers by Zhenwei Deng Breakdown of academic impact, for papers by Marall Vedaie
Rankless by CCL
2026